본문 바로가기

Effects of beta-blockers for congestive heart failure in pediatric and congenital heart disease patients: a meta-analysis of published studies

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q4Scopus Q3
저널
MINERVA CARDIOANGIOLOGICA63(6) · pp.495 · 2015
피인용
Web of Science 9
JCR IF
JCR 2014 0.53
ISSN
0026-4725

저자

  1. 조민정제1저자부산대학교, 부산대학교병원, 대학병원, KO
  2. 임령경부산대학교, 부산대학교병원, 대학병원, KO
  3. 곽민정부산대학교, 의과대학, 의학과, KO
  4. 박경희부산대학교, 의과대학, 의학과, KO
  5. 김혜영부산대학교, 부산대학교병원, 대학병원, Sch Med, KO
  6. 김영미부산대학교, 의과대학, 의학과, KO
  7. 이형두부산대학교, 의과대학, 의학과, 소아과학교실, KO

초록

Aim. The effects of beta-blockers in pediatric and congenital heart disease (CHD) patients suffering from heart failure are controversial. We performed a meta-analysis to determine whether beta-blockers are effective for heart failure in pediatric and CHD patients. Methods. We searched for clinical trials focusing on clinical on clinical and ventricular functional/dimensional changes after beta-blocker therapy in PubMed (from its inception to August 2013) and bibliographies of identified studies. Studies investigating any of three beta blockers (carvedilol, bisoprolol, and extended release metoprolol succinate) which are known to be effective in adult patients with heart failure were included. Results. Of the 158 screened, 17 (N.=476) fulfilled the study criteria and were analyzed. Beta-blockers were associated with significant improvements in left ventricular (LV) ejection fraction (EF) (12.47%; 95% CI, 10.36 to 14.61), fraction shortening (5.75%; 95% CI, 4.42 to 7.08), LV end-diastolic dimension (-2.91 mm; 95% CI, -5.46 to -0.36), and LV systolic dimension (-4.03 mm; 95% CI, -6.81 to -1.25). No significant change in the pooled mean difference of the right ventricular (RV) EF (3.50%; P=0.08) was observed. However, the RV EF in the untreated group showed a deteriorating trend (-3%), which was different from the trend in the treatment group. There was a significant reduction in the incidence of clinical worsening (odds ratio, 2.15; 95% CI, 1.27 to 3.66). Conclusion. Beta-blocker therapy was as sociated with a significant improvement of echocardiographic parameters in patients with systemic LV failure. However, the use of beta-blockers did not provide significant benefits in terms of improving the EF in patients with RV failure. Nonetheless, beta-blockers may be effective to prevent the clinical deterioration of pediatric and CHD patients with heart failure.

키워드

Heart failureHeart defects, congenitalPediatricsBeta-blockersMeta-analysisIDIOPATHIC DILATED CARDIOMYOPATHYCARVEDILOL THERAPYDOUBLE-BLINDVENTRICULAR DYSFUNCTIONCONTROLLED-TRIALCHILDRENINFANTSMETOPROLOLMANAGEMENTMORTALITY

식별자

WoS UID
000369556800004